A Nanomaterial-Integrated Paper Microfluidic Device for Detecting and Predicting Myocardial Infarctions
Cardiovascular disease kills 17.9 million people globally each year. 85% of these deaths were caused by either a myocardial infarction (heart attack) or stroke. Current tests for predicting heart attacks provide rapid results when presented with a blood sample, but these samples must be preprocessed using time-consuming methods. This project will develop a paper-based platform to detect heart attack markers in blood without external preprocessing. This will be accomplished by integrating a blood processing device into the testing platform. Ideally, this platform will predict heart attacks within five minutes of drawing blood from patients, facilitating life-saving medical treatment. The partner organization, Mitra Biotechnologies, previously developed a paper-based blood processing device. They are now partnering with researchers at the University of Waterloo with expertise in paper-based medical tests to turn this device into an all-in-one blood processing and testing platform that can be brought to market to save lives.
Voir la description complète du projetSushanta Mitra
Mitra Biotechnologies Inc.
Life Sciences
Manufacturing
University of Waterloo
Accelerate